Genetic Causes of Troyer Syndrome in Omani Families
Author Information
Author(s): M. Chiara Manzini, Anna Rajab, Thomas M Maynard, Ganeshwaran H Mochida, Wen-Hann Tan, Ramzi Nasir, R Sean Hill, Danielle Gleason, Muna Al Saffar, Jennifer N Partlow, Brenda J Barry, Mike Vernon, Anthony-Samuel LaMantia, Christopher A Walsh
Primary Institution: Children's Hospital Boston, Harvard Medical School
Hypothesis
We sought to explore the genetic and molecular causes of Troyer syndrome, one of several complicated hereditary spastic paraplegias (HSPs).
Conclusion
Null mutations in SPG20 cause Troyer syndrome, which is characterized by developmental and degenerative features.
Supporting Evidence
- Two Omani families with a novel SPG20 mutation displayed clinical features similar to Amish patients with Troyer syndrome.
- SPG20 mRNA is expressed broadly but at low levels in the adult brain, and robustly in limbs and face during early development.
- The identified mutation is not present in control individuals, indicating it is not a common polymorphism.
Takeaway
This study found that a genetic mutation causes a condition called Troyer syndrome, which affects how children grow and develop.
Methodology
Clinical characterization, linkage and sequencing analysis, and expression analysis of SPG20 in human and mouse tissues.
Limitations
The study is limited by the small sample size and the variability of symptoms in young subjects.
Participant Demographics
Two Omani families with affected individuals presenting with short stature, dysarthria, and developmental delay.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website